Chronic Fatigue Therapy
Active substance: SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS LEAFY TWIG, GINKGO, CHELIDONIUM MAJUS, EPINEPHRINE, PHOSPHORIC ACID, ECHINACEA, UNSPECIFIED, GOLD, HELLEBORUS NIGER ROOT
TABLET, ORALLY DISINTEGRATING · SCUTELLARIA LATERIFLORA 6 [hp_X]/1, THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/1, GINKGO 3 [hp_X]/1, CHELIDONIUM MAJUS 6 [hp_X]/1, EPINEPHRINE 7 [hp_X]/1, PHOSPHORIC ACID 6 [hp_X]/1, ECHINACEA, UNSPECIFIED 3 [hp_X]/1, GOLD 8 [hp_X]/1, HELLEBORUS NIGER ROOT 6 [hp_X]/1
United StatesActive
Marketing holder: TRP Company
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SCUTELLARIA LATERIFLORA · 6 [hp_X]/1
- THUJA OCCIDENTALIS LEAFY TWIG · 6 [hp_X]/1
- GINKGO · 3 [hp_X]/1
- CHELIDONIUM MAJUS · 6 [hp_X]/1
- EPINEPHRINE · 7 [hp_X]/1
- PHOSPHORIC ACID · 6 [hp_X]/1
- ECHINACEA, UNSPECIFIED · 3 [hp_X]/1
- GOLD · 8 [hp_X]/1
- HELLEBORUS NIGER ROOT · 6 [hp_X]/1
Products containing epinephrine in other countries
Registration
- Registration number
- 17312-170
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source
- ingredients.8 · openFDA NDC · 17312-170 · Verified 2026-10-09 · open in source